Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Public knowledge, beliefs, and treatment preferences concerning attention-deficit hyperactivity disorder.

McLeod JD, Fettes DL, Jensen PS, Pescosolido BA, Martin JK.

Psychiatr Serv. 2007 May;58(5):626-31.

2.

Knowledge and information about ADHD: evidence of cultural differences among African-American and white parents.

Bussing R, Schoenberg NE, Perwien AR.

Soc Sci Med. 1998 Apr;46(7):919-28.

PMID:
9541077
3.
4.

Public attitudes towards the acceptability of using drugs to treat depression and ADHD.

Partridge B, Lucke J, Hall W.

Aust N Z J Psychiatry. 2012 Oct;46(10):958-65. doi: 10.1177/0004867412450755. Epub 2012 Jun 11.

PMID:
22689334
5.

Public knowledge and assessment of child mental health problems: findings from the National Stigma Study-Children.

Pescosolido BA, Jensen PS, Martin JK, Perry BL, Olafsdottir S, Fettes D.

J Am Acad Child Adolesc Psychiatry. 2008 Mar;47(3):339-49. doi: 10.1097/CHI.0b013e318160e3a0.

PMID:
18216729
8.

Educating and counseling of parents of children with attention-deficit hyperactivity disorder.

Ghanizadeh A.

Patient Educ Couns. 2007 Sep;68(1):23-8. Epub 2007 Apr 27.

PMID:
17467224
9.

Youth Views on Communication About ADHD and Medication Adherence.

Sleath B, Carpenter DM, Sayner R, Thomas K, Mann L, Sage A, Sulzer SH, Sandler AD.

Community Ment Health J. 2017 May;53(4):438-444. doi: 10.1007/s10597-016-0078-3. Epub 2017 Jan 10.

PMID:
28074407
10.

Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.

Zwi M, Jones H, Thorgaard C, York A, Dennis JA.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD003018. doi: 10.1002/14651858.CD003018.pub3. Review.

PMID:
22161373
11.

The impact of long-acting medications on attention-deficit/hyperactivity disorder treatment disparities.

Saloner B, Fullerton C, McGuire T.

J Child Adolesc Psychopharmacol. 2013 Aug;23(6):401-9. doi: 10.1089/cap.2012.0019.

12.

Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder.

Frazier TW, Shattuck PT, Narendorf SC, Cooper BP, Wagner M, Spitznagel EL.

J Child Adolesc Psychopharmacol. 2011 Dec;21(6):571-9. doi: 10.1089/cap.2011.0057. Epub 2011 Dec 13.

13.

Primary school teachers' attitudes about children with attention deficit/hyperactivity disorder and the role of pharmacological treatment.

Moldavsky M, Pass S, Sayal K.

Clin Child Psychol Psychiatry. 2014 Apr;19(2):202-16. doi: 10.1177/1359104513485083. Epub 2013 Apr 26.

PMID:
23625952
14.
15.

Racial differences in parental reports of attention-deficit/hyperactivity disorder behaviors.

Hillemeier MM, Foster EM, Heinrichs B, Heier B; Conduct Problems Prevention Research Group.

J Dev Behav Pediatr. 2007 Oct;28(5):353-61.

16.

ADHD knowledge, perceptions, and information sources: perspectives from a community sample of adolescents and their parents.

Bussing R, Zima BT, Mason DM, Meyer JM, White K, Garvan CW.

J Adolesc Health. 2012 Dec;51(6):593-600. doi: 10.1016/j.jadohealth.2012.03.004. Epub 2012 Apr 17.

17.
18.

Knowledge and attitudes towards attention deficit hyperactivity disorder among elementary school teachers.

Ghanizadeh A, Bahredar MJ, Moeini SR.

Patient Educ Couns. 2006 Oct;63(1-2):84-8. Epub 2006 Feb 28.

PMID:
16504452
19.

Physician perceptions of the use of medications for attention deficit hyperactivity disorder.

Stockl KM, Hughes TE, Jarrar MA, Secnik K, Perwien AR.

J Manag Care Pharm. 2003 Sep-Oct;9(5):416-23.

20.

ADHD medication use following FDA risk warnings.

Barry CL, Martin A, Busch SH.

J Ment Health Policy Econ. 2012 Sep;15(3):119-25.

Supplemental Content

Support Center